Facebook-f X-twitter Linkedin-in

CLENE, INC.: GENERAL TERMS AND CONDITIONS OF USE

Effective Date: May 27, 2024

These terms of use are entered into by and between You and Clene. The following terms and conditions (collectively, “Terms of Use”), govern your access to and use of: (i) https://clene.com/, (ii) www.clenecompassionateuse.com, and (iii) any other websites provided by Clene, Clean Nanomedicine, Inc., and their affiliates (collectively, “Clene”, “we,” or “us,” or “our”) that link to these Terms of Use, including informational sites posted by Clene Nanomedicine, Inc. (the “Clene Websites”).

BY USING THE CLENE WEBSITES YOU ACCEPT AND AGREE TO BE BOUND AND ABIDE BY THESE TERMS OF USE AND OUR PRIVACY POLICY (https://clene.com/privacy-policy) INCORPORATED BY REFERENCE IN THE TERMS OF USE.

IF YOU DO NOT WANT TO AGREE TO THESE TERMS OF USE OR THE PRIVACY POLICY, YOU SHOULD NOT ACCESS OR USE THE CLENE WEBSITES.

  1. Not a Substitute for Medical Advice.
    The Clene Websites are provided for educational and information purposes only and are not intended to be a substitute for medical advice, diagnosis, treatment, or other professional services. Users should always seek the advice of physician or other qualified healthcare provider with any questions regarding a medical condition.
  2. Participating Institutions.
    Clene sponsors certain clinical trials and expanded/early access programs (each an “EAP”), and this sponsorship consists of, among other tasks and management responsibilities: (i) engaging and managing the third-party institutions that conduct the clinical trials and EAPs (each a “Participating Institution”); (ii) requiring these Participating Institutions to adhere to our drug and program protocols; and (iii) providing funding for the Participating Institutions to conduct the EAPs and clinical trials. Clene may provide information on how prospective participants may locate additional information regarding the EAPs; however, the websites offered by Participating Institutions are subject to the terms and conditions provided by such Participating Institutions and, unless otherwise agreed, Clene is not responsible for the content or services provided by Participating Institutions.
  3. Third Party Websites.
    The Clene Websites may contain links to third party websites (other than those of our Participating Institutions). We are not responsible for the content on those websites, and your use of those websites will be governed solely by the terms and conditions provided by the third party at issue.
  4. Changes to the Clene Websites & Terms of Use.
    1. We may revise or make changes to the Clene Websites or these Terms of Use at any time in our sole discretion. All changes are effective immediately when we post them and apply to all access to and use of the Clene Websites after the changes have been posted. However, any changes to the dispute resolution provisions set out in Governing Law and Jurisdiction will not apply to any disputes that arose before the date the change is posted on the Clene Websites.
    2. Your continued use of the Clene Websites following changes to the content or the posting of revised Terms of Use means You accept and agree to the changes. We will notify you of material changes to the Terms of Use before they take effect. You should check this page from time to time, so you are aware of any changes, as they are binding on you.
    3. We will not be liable if for any reason all or any part of the Clene Websites is unavailable at any time or for any period. From time to time, we may restrict access to some parts of the Clene Websites, or the entire Clene Websites, to users, including registered users.
  5. Acceptable Use & Restrictions.
    1. The Clene Websites may be used only for lawful purposes and in a lawful manner consistent with these Terms of Use. In connection with your use of the Clene Websites, you must comply with all laws, ordinances, rules, regulations, orders, licenses, permits, judgments, decisions, and other requirements of any governmental authority that has jurisdiction over you, us, or the material on the Clene Websites (collectively, “Applicable Law”).
    2. You agree not to use the Clene Websites:
      1. In any way that violates Applicable Law, including, without limitation, any laws regarding encryption or the export of data or software to and from the U.S. or other countries.
      2. To attempt to or to actually exploit or harm any minor in any way by exposing them to inappropriate content, asking for personally identifiable information, or otherwise.
      3. To send, knowingly receive, upload, download, use, or re-use any material that does not comply with the requirements set out in these Terms of Use.
      4. To transmit, or procure the sending of, any advertising or promotional material without our prior written consent, including any “junk mail,” “chain letter,” “spam,” or any similar solicitation.
      5. To impersonate or attempt to impersonate Clene, a Clene employee, another user, or any other person or entity, including, without limitation, by using any associated email addresses or screen names.
      6. To engage in any other conduct that restricts or inhibits anyone’s use or enjoyment of the Clene Websites, or which, as determined by us, may harm Clene or users of the Clene Websites, or expose them to liability.
    3. In using the Clene Websites, you also agree not to:
      1. Use the Clene Websites in any manner that could disable, overburden, damage, or impair the Clene Websites or interfere with any other party’s use of the Clene Websites, including their ability to engage in real time activities through the Clene Websites.
      2. Use any robot, spider, or other automatic device, process, or means to access the Clene Websites for any purpose, including monitoring or copying any of the material on the Clene Websites.
      3. Use any manual process to monitor or copy any of the material on the Clene Websites, or for any other purpose not expressly authorized in these Terms of Use, without our prior written consent.
      4. Use any device, software, or routine that interferes with the proper working of the Clene Websites.
      5. Introduce any viruses, Trojan horses, worms, logic bombs, or other material that is malicious or technologically harmful.
      6. Attempt to gain unauthorized access to, interfere with, damage, or disrupt any parts of the Clene Websites, the server on which the Clene Websites is hosted, or any server, computer, or database connected to the Clene Websites.
      7. Attack the Clene Websites via a denial-of-service attack or a distributed denial-of-service attack.
      8. Otherwise attempt to interfere with the proper working of the Clene Websites.
  6. Data Protection & Privacy.
    All information We collect on the Clene Websites is subject to our Privacy Policy (https://clene.com/privacy-policy), and We will only use Your information accordingly. By using the Clene Websites, you consent to all actions taken by Us with respect to your information in compliance with the Privacy Policy. Please read the Privacy Policy (https://clene.com/privacy-policy) carefully.
  7. User Generated Content.
    1. The Clene Websites may contain personal profiles, discussion forums, file upload forms, interactive leaderboards, submit an idea form, express interest form and other interactive features (collectively, “Interactive Services”) that allow users to post, submit, publish, display, or transmit to other users or other persons (hereinafter, “post”) content or materials (collectively, “User Content”) on or through the Clene Websites.
    2. All User Content must comply with the requirements set out in these Terms of Use.
    3. Any User Content you post to the Clene Websites will be considered non-confidential and non-proprietary. By providing any User Content on the Clene Websites, you grant us and each of our licensees, successors, and assigns the perpetual, irrevocable, royalty-free, worldwide right to use, reproduce, modify, perform, display, distribute, and otherwise disclose to third parties any such material for any purpose.  You hereby waive any and all moral rights you have in any User Content you provide on the Clene Websites.
    4. You represent and warrant that:
      1. You own or control all rights in and to the User Content and have the right to grant the license granted above.
      2. Your User Content complies with these Terms of Use.
      3. You understand and acknowledge that you are responsible for any User Content you submit or contribute, and you, not Clene, have full responsibility for such content, including its legality, reliability, accuracy, and appropriateness.
      4. You will not provide sensitive health information or other health-related information through contact forms on the Clene Websites.
    5. We reserve the right, at any time, to:
      1. Remove or refuse to post any User Content for any or no reason in our sole discretion.
      2. Take any action with respect to any User Content that we consider appropriate in our sole discretion, including if we believe that such User Contribution violates the Terms of Use, infringes any intellectual property right or other right of any person or entity, threatens the personal safety of users of the Clene Websites or the public, or could create liability for Clene.
    6. We are not responsible or liable to any third party for the content or accuracy of any User Content posted by you or any other user of the Clene Websites.
  8. Intellectual Property Rights.
    1. All information, software, artwork, text, video, audio, pictures, logos, and other content on the Clene Websites, including all associated intellectual property rights, are the property of Clene and its licensors, and are protected by copyright and other intellectual property laws, or are included based on principles of “fair use.” Clene retains all rights with respect to the Clene Websites except those expressly granted to you in these Terms of Use.
    2. The Clene Inc. name, the Clene Nanomedicine Inc. name, the logos, and all related names, logos, product and service names, designs, and slogans are trademarks or service marks of Clene or its licensors. You must not use such marks without the prior written permission of Clene. All other names, logos, product and service names, designs, and slogans on this Clene Websites are the trademarks of their respective owners.
    3. These Terms of Use permit you to use the Clene Websites for your personal, non-commercial use only. You are permitted to reproduce, distribute, modify, create derivative works of, publicly display, publicly perform, republish, download, store, or transmit any of the material (including research and training material) on our Clene Websites only for the following reasons:
      1. You may temporarily store copies of such materials in RAM incidental to accessing and viewing those materials.
      2. You may store files that are automatically cached by your web browser for display enhancement purposes.
      3. You may download, store, or print copies of material on the Clene Websites for your own personal, non-commercial use and not for further reproduction, publication, or distribution.
    4. In using the Clene Websites, you agree not to:
      1. modify copies of any materials from the Clene Websites;
      2. use any illustrations, photographs, video or audio sequences, or any graphics separately from the accompanying text;
      3. delete or alter any copyright, trademark, or other proprietary rights notices from copies of materials from this site;
    5. If you wish to make any use of material on the Clene Websites other than that set out in this section, please address your request to: administer@clene.com.
    6. If you print, copy, modify, download, or otherwise use or provide any other person with access to any part of the Clene Websites in breach of the Terms of Use, your right to use the Clene Websites will stop immediately and you must, at our option, return or destroy any copies of the materials you have made. No right, title, or interest in or to the Clene Websites or any content on the Clene Websites is transferred to you, and all rights not expressly granted are reserved by the Company. Any use of the Clene Websites not expressly permitted by these Terms of Use is a breach of these Terms of Use.
    7. If you believe that any User Content or other material on the Clene Websites violates your copyright, please send an email to administer@clene.com notifying us of the copyright infringement so that we may investigate the matter further and take the appropriate action.
  9. External Clene Websites & Applications.
    1. You may link to our homepage, provided you do so in a way that is fair and legal and does not damage our reputation or take advantage of it, but you must not establish a link in such a way as to suggest any form of association, approval, or endorsement on our part without our express written consent.
    2. You agree to only use social media features on the Clene Websites as they are provided by us, and solely with respect to the content they are displayed with, and otherwise in accordance with any additional terms and conditions we provide with respect to such features.
    3. The Clene Websites may contain links or produce search results that reference links to third-party
      websites (collectively “Linked Sites”). Clene has no control over these Linked Sites or their content and does not assume responsibility or liability for any content, opinions, or materials available on Linked Sites. Clene does not endorse the content of any Linked Site, nor does Clene warrant that a Linked Site will be free of computer viruses or other harmful or malicious code that could impact your computer or other web-access device. By using the Clene Websites to search for or link to another site, you agree and understand that use of any Linked Sites is at your own risk.
  10. DISCLAIMER OF WARRANTIES & LIMITATION OF LIABILITY.
    THE CLENE WEBSITES, AS WELL AS ANY INFORMATION AND MATERIALS PROVIDED THEREON, THEIR PERFORMANCE AND AVAILABILITY ARE PROVIDED AS IS, AS AVAILABLE, AND WITH ALL FAULTS. TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, WE MAKE NO REPRESENTATIONS OR WARRANTIES OF ANY KIND, EXPRESS OR IMPLIED, AS TO THE OPERATION OF THE WEBSITE, ANY MATERIALS, OR THE PAYMENT PROCESSING SERVICE THEIR PERFORMANCE, AVAILABILITY, OR RESULTS. AND DISCLAIM ANY AND ALL REPRESENTATIONS OR WARRANTIES OF ANY KIND, EXPRESS OR IMPLIED, INCLUDING WITHOUT LIMITATION: (A) ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, TITLE, OR NON-INFRINGEMENT; (B) ANY WARRANTY THAT THE CLENE WEBSITES, SUCH MATERIALS, THE INFORMATION, OR THEIR PERFORMANCE WILL MEET YOUR REQUIREMENTS, WILL ALWAYS BE AVAILABLE, ACCESSIBLE, UNINTERRUPTED, TIMELY, SECURE, OPERATE WITHOUT ERROR, OR WILL CONTAIN ANY PARTICULAR FEATURES OR FUNCTIONALITY; (C) ANY WARRANTY AS TO ACCURACY OF ANY INFORMATION, CONTENT, MATERIALS, OR SUBMISSIONS AVAILABLE ON THE WEBSITE; OR (D) ANY IMPLIED WARRANTY ARISING FROM COURSE OF DEALING OR USAGE OF TRADE. THE CLENE WEBSITES, AND THE INFORMATION AND MATERIALS PROVIDED THEREON, ARE PROVIDED FOR INFORMATIONAL PURPOSES ONLY AND ARE NOT A SUBSTITUTE FOR MEDICAL ADVICE AND SHOULD NOT BE RELIED UPON AS SUCH.
  11. Indemnification.
    You agree to defend, indemnify, and hold harmless Clene, its licensors, and service providers, and its and their respective officers, directors, employees, contractors, agents, licensors, suppliers, successors, and assigns from and against any and all claims, liabilities, damages, judgments, awards, losses, costs, expenses, or fees (including reasonable attorneys’ fees) arising out of or relating to your violation of these Terms of Use or your use of the Clene Websites, including, but not limited to, your User Content, any use of the Clene Websites’ content, services, and products other than as expressly authorized in these Terms of Use, or your use of any information obtained from the Clene Websites.
  12. Enforcement; Termination.
    1. We reserve the right to at any time:
      1. Disclose your identity or other information about you to any third party who claims that material posted by you violates their rights, including their intellectual property rights or their right to privacy
      2. Take appropriate legal action, including without limitation, referral to law enforcement, for any illegal or unauthorized use of the Clene Websites.
    2. YOU AGREE TO WAIVE AND HOLD HARMLESS CLENE AND ITS LICENSEES, AND SERVICE PROVIDERS AND ITS AND THEIR OFFICERS, DIRECTORS, EMPLOYEES, AGENTS, AND REPRESENTATIVES FROM ANY CLAIMS RESULTING FROM ANY ACTION TAKEN BY CLENE IN RESPONSE TO ANY INVESTIGATION BY EITHER CLENE OR GOVERNMENTAL AUTHORITIES.
  13. Governing Law & Dispute Resolution.
    1. Any and all claims or proceedings arising out of or relating to the Clene Websites or these Terms of Use, in each case, including non-contractual claims or proceedings, will be governed by and construed in accordance with the laws of the State of Delaware without giving effect to any choice or conflict of law provision or rule that would provide otherwise.
    2. Any and all claims or proceedings arising out of or relating to the Clene Websites or these Terms of Use, in each case, including non-contractual claims or proceedings, must be instituted exclusively in the federal courts of the United States or the courts of the State of Delaware, located in the City of Wilmington and the New Castle County, although we retain the right to bring any suit, action, or proceeding against you for breach of these Terms of Use in your state or country of residence. You waive any and all objections to the exercise of jurisdiction over you by the courts and to venue in the courts listed above. To the fullest extent by law, each party hereby irrevocably waives its rights to trial by jury in any claim or proceeding arising out of or relating to the Clene Websites or these Terms of Use.
  14. Waiver & Severability.
    If any provision of these Terms of Use is held by a court or other tribunal of competent jurisdiction to be invalid, illegal, or unenforceable for any reason, that provision will be eliminated or limited to the minimum extent such that the remaining provisions of the Terms of Use will continue in full force and effect.
  15. Entire Agreement.
    The Terms of Use and our Privacy Policy constitute the sole and entire agreement between you and Clene regarding the Clene Websites and any services related to your use of or participation in the Clene Websites and supersede all prior and contemporaneous understandings, agreements, representations, and warranties, both written and oral, regarding the Clene Websites. Except to the extent expressly stated herein or in an written agreement between you and Clene, the Clene Websites and any statements or information contained therein is not, and should not be construed as, an offer, guarantee, or promise of any nature and does not create any obligations of Clene.
  16. Comments & Concerns.
    1. This website is operated by Clene, the headquarters of which is located at 6550 South Millrock Drive, Suite G50, Salt Lake City, Utah 84121.
    2. All feedback, comments, requests for technical support, and other communications relating to the Clene Websites should be directed to: administer@clene.com.

Mark Mortenson

Chief Science Officer

Mr. Mortenson is the co-inventor of the technology platform developed to produce Clene’s Clean-Surface Nanocrystal (CSN™) therapeutics, as well as the inventor/co-inventor for 30 other U.S. patents and hundreds of corresponding foreign patents.

Prior to joining Clene, Mr. Mortenson served as former Chief Operating Officer of Research, Development and Manufacturing for an advanced materials-based company of more than 300 employees. In addition to his professional experience, he is a former chief patent counsel responsible for approximately 5,500 patents and patent applications in the U.S. and 44 foreign countries. Mr. Mortenson holds both a Bachelor of Science in physics and a Bachelor of Science in ceramic engineering from Alfred University, a Master of Science in material science from Pennsylvania State University, and a Juris Doctor degree from George Washington University.

Rob Etherington

President & CEO

Mr. Etherington brings nearly 30 years of sales, marketing and leadership experience in the pharmaceutical industry to Clene. Prior to joining Clene as CEO, Mr. Etherington worked for Actelion Pharmaceuticals, which was the largest biopharmaceutical company based in the EU until Johnson & Johnson Pharmaceuticals acquired the company in 2017. He initially joined Actelion as founding Director of Marketing in 2000, the same year the company went public, and went on to hold various roles of increasing responsibility. Mr. Etherington served as the first U.S. commercial employee, leading U.S. commercial operations and serving as Chair of the U.S. Commercial Strategic team where he was responsible for five marketed drugs. Prior to Actelion, Mr. Etherington began his pharmaceutical career with a number of sales and marketing roles at Parke-Davis, a division of Pfizer, culminating in a Team Leader position that oversaw the drug Lipitor. As the founding CEO of Clene, Mr. Etherington has raised more than $150M in equity financings, and has driven Clene’s focus on neurodegenerative diseases.

Joanne Zhongyan Zhang M.D., PhD

Director of Micro and Biology

Joanne Zhongyan Zhang is the Director of Micro and Biology at Clene. Dr. Zhang has spent more than 20 years in medical research and is an experienced leader in quality control microbiology laboratory and scientific research in biology. Dr. Zhang helped design, and personally executed the initial and validated Cuprizone Studies of Clene’s asset, CNM Au8, suggesting that Au8 may enhance remyelination in MS. Dr. Zhang designed and directed the ALS pilot study proving that Au8 improved the motor coordination in congenic ALS SOD1 G93A mouse model. Both MS and ALS are now in Clinical Trial Phase II. Dr. Zhang brings to Clene both clinical experience and a successful medical research background. She spent over six years working as an attending physician and chief physician at Tianjin First Central Hospital. Dr. Zhang was a postdoctoral fellow in Cell Biology at Johns Hopkins University; she worked as research associate in the Cardiology Department at Duke University; and prior to Duke was awarded Special Fellow status by the Japan Society for the Promotion of Science while working at Osaka University. Dr. Zhang was awarded her medical degree from Tianjin Medical University and received her PhD from the Cardiology Division of Internal Medicine and Molecular Science at Osaka University.

D. Kyle Pierce

Vice President, Research & Development

D. Kyle Pierce is the Executive Director of Nano-Engineering at Clene. Mr. Pierce has been with Clene since its inception. Mr. Pierce oversees the R&D department, designed the production equipment and software which Clene uses in its manufacturing of their key asset, and developed production procedures. He started his carrier in an antecedent technology and development company, General Resonance, as a Senior Engineer developing the technology used for Clene’s production equipment. While attending the University of Maryland at College Park, where he received a BS in Electrical Engineering, he worked for the Army Material System Analysis Activity (AMSAA DoD). While at AMSAA Mr. Pierce debugged and maintained an active protection performance model software, he was issued a Secret Security Clearance from the Department of Defense. While at Clene, he has co-authored numerous peer reviewed publications.

Austin Rynders

Vice President, Clinical Operations

Austin Rynders is the Vice President of Clinical Operation at Clene. Mr. Rynders is a multi-faceted professional with over 10 years of clinical experience heavily focused in CNS/pain methodology with an emphasis in investigational pain modeling, abuse potential, degenerative disorders, and unique early proof-of-concept study development across Phase I-III studies. With participation and oversight of over 200 clinical trials prior to joining Clene, Mr. Rynders’ exposure to complex and unique study designs has allowed for development of a robust clinical mindset and multiple key accomplishments. These accomplishments include the development and implementation of validated methodologies surrounding ventilatory responses to hypercapnia and quantitative sensory testing, development and beta testing of cognition-based assessment platforms, operational reorganization of multiple clinical operations teams, and the expansion and development of a purpose built 136 bed Phase 1 facility. Mr. Rynders has received a Bachelor of Nursing from the University of Utah and will soon obtain his Master of Science in Pharmacology and Toxicology from Michigan State University.

Adam Dorfman

Vice President, Quality & Technical Operations

Adam Dorfman is the Executive Director of Quality Control and Bioanalytical at Clene. Mr. Dorfman has over 13 years of experience in various roles including nanoparticle development and characterization, specimen bioanalysis, and quality control. Mr. Dorfman has been with Clene since 2013 and is responsible for ensuring that the finished pharmaceuticals meet all quality standards for Clene’s active clinical trials. In addition, he leads the bioanalytical group that analyzes all GLP/GCP tissue and pharmacokinetic specimens that are collected during pre-clinical and clinical activities. Mr. Dorfman was originally tasked with establishing a GMP/GLP compliant lab at Clene, and more recently has been responsible for developing and implementing Clene’s laboratory informatics system that will streamline all manufacturing and quality control processes. He has a BS in Chemical Engineering from The Pennsylvania State University and MS in Chemical and Biomolecular Engineering from Johns Hopkins University.

Mary Anne McNeil

Head of Human Resources

Mary Anne McNeil is the Head of Human Resources at Clene. Ms. McNeil is an accomplished professional with a diverse and successful career in human resources, management and marketing. Prior to joining Clene, Ms. McNeil served as the EVP of Human Resources, Marketing and Sales for a successful art business, where she executed a company culture of diversity, career development, and an outstanding sales force. While there, sales increased by 40%, the employee retention rate doubled and the signing of new artists to represent increased by over 12%. Ms. McNeil is creating a company culture which encourages diversity, growth and learning, open communication and accessibility, recognition for exemplary work, long term careers while striving to make Clene a leading and desirable place of employment. She has started a management training program by working with a local college, has implemented a review and raise process, has encouraged career mapping with all Clene colleagues which has led to many promotions within the company, assisted in developing a comprehensive training program and is working with workforce services to employ individuals from the local area. doubled. She is excited for the future of Clene and looks forward to its success and many upcoming milestones.

Jerry Miraglia, J.D.

General Counsel and Corporate Secretary

Mr. Miraglia has advised small private companies and large public companies, ranging from startups with only an idea to Fortune 125 companies. Most recently, he led the M&A legal team at Jabil Inc (NYSE: JBL), a contract manufacturer with 250,000+ employees operating in 30+ countries, including its medical solutions healthcare division. Mr. Miraglia spent the first 14 years of his legal career in Baltimore, joining Miles & Stockbridge out of law school and becoming a full equity partner in their corporate department, advising such clients as Black & Decker. Mr. Miraglia left Miles to serve as General Counsel for an interactive entertainment company, and subsequently entered the business world and served as EVP for Dover Motorsports (NYSE: DVD) and ultimately President of a media company. Mr. Miraglia’s diverse background navigating both business and legal aspects of corporate transactions, manufacturing, sales, marketing and distribution, providing Clene with a unique blend of insights as it leaves the private sector and enters the public.

Michael Hotchkin

Chief Development Officer

Mr. Hotchkin brings more than 20 years of experience in pharmaceutical commercialization, planning, strategy development, and medical affairs to Clene, where he currently leads commercial planning and strategy development, preclinical translational medicine, and health regulatory authority filings. Prior to joining the company, Mr. Hotchkin was a founding team member at Actelion Pharmaceuticals US, Inc., where he helped launch multiple best-in-class products for orphan disorders. Having spent more than a decade at Actelion, Mr. Hotchkin led the commercialization efforts for the company’s Genetic Business Unit, including clinical development activities which resulted in the doubling of sales for two different pharmaceutical drugs. Among his contributions while at Actelion include the implementation of new market planning activities for the company globally, directing U.S. strategy development and leading marketing activities for multiple medicines. Mr. Hotchkin began his career at Parke-Davis, a subsidiary of Pfizer.

Morgan Brown

Chief Financial Officer

Mr. Morgan Brown has more than 29 years of finance and accounting experience with the last twenty-two years servicing biotechnology, pharmaceutical, medical device and clinical research companies.  Prior to joining Clene as CFO, Mr. Brown served in a similar capacity at Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company; at Innovus Pharmaceuticals, Inc. (OTCBB: INNV), an emerging pharmaceuticals company; at World Heart Corporation (NASDAQ: WHRT), a medical device company; at Lifetree Clinical Research, a clinical research organization; and, at NPS Pharmaceuticals Inc. (NASDAQ: NPSP), a biotechnology company.  Previously he worked for KPMG LLP, an international public accounting firm, in Salt Lake City where he served as a Senior Audit Manager. In his roles prior to Clene, Mr. Brown has participated in and led efforts to successfully evaluate, negotiate, and close transactions including equity and debt financings totaling over $1 billion and out-licensing of commercial stage asset transactions totaling $220 million. Mr. Brown has experience in sale-leaseback arrangements, facilities construction, and M&A activities.  Mr. Brown is a licensed certified public accountant in the state of Utah. Mr. Brown earned a Master of Science degree in Business Administration from the University of Utah and a Bachelor of Science degree in Accounting from Utah State University.

Benjamin Greenberg, MD, MHS, FAAN

Head of Medical

Dr. Benjamin Greenberg is an internationally recognized expert in disorders of the central nervous system. He joins Clene alongside his current role as professor of neurology and Vice Chair of Clinical and Translational Research in the Department of Neurology at UT Southwestern Medical Center in Dallas, TX.

His clinical and research expertise spans many areas of neurology including the diagnosis and treatment of MS and other rare neurological disorders. Dr. Greenberg received his Bachelor’s degree from Johns Hopkins University and his Master’s degree in Molecular Microbiology and Immunology from the Johns Hopkins School of Public Health. He graduated from Baylor College of Medicine and completed an internal medicine internship at Rush Presbyterian-St. Luke’s Medical Center in Chicago, before going on to residency in neurology at The Johns Hopkins Hospital in Baltimore.

Rowena Green

Executive Director, Quality Assurance

Rowena Green joined Clene Nanomedicine, Inc. in 2015, with experience in the (bio)pharmaceutical, nutraceutical, medical device and environmental industries. With over twenty-three years of GxP experience, eighteen years are as a quality assurance representative, which confirms her role as Sr. Director of Quality Assurance. Prior to Clene, Rowena spent three years as a consultant at Meridian BioGroup. There, she supported multiple clients to ensure compliance to the appropriate regulations (i.e., GMPs, GLPs). Prior to being a consultant, Rowena worked with Johns Hopkins University as the Quality Manager of the Cell Processing and Gene Therapy Department, which manufactured clinical trial material for multiple JHU Investigators. With a Bachelor of Science Degree in Chemistry, Rowena has worked as a Manufacturing Operator to produce brain cancer treatment, developed clinical trial projects to manufacture API as a Research Associate in Chemical Development, and performed the data review for one of the largest MRSA clinical studies ever conducted as a Sr. Quality Assurance representative. Rowena’s experience in the various industries has led her to Clene, where she and her direct reports provide regulatory support and quality assurance oversight for at least seven on-going clinical studies.